TRANSFORMATIVE IMMUNOTHERAPIES TO TREAT DISEASES LINKED TO AGING AND CHRONIC INFLAMMATION
HCW Biologics(NASDAQ: HCWB) is a clinical-stage biopharmaceutical company developing proprietary immunotherapies to treat diseases promoted by chronic inflammation, especially age-related and senescence-associated diseases.
IMMUNOTHERAPY FOR INFLAMMAGING
HCW Biologics is a clinical-stage company advancing development of transformative immunotherapies to lengthen healthspan by disrupting inflammaging.
